PHARMANUTRA SPA (PHN.MI) Stock Fundamental Analysis
BIT:PHN - Euronext Milan - IT0005274094 - Common Stock - Currency: EUR
Overall PHN gets a fundamental rating of 7 out of 10. We evaluated PHN against 14 industry peers in the Personal Care Products industry. PHN has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. PHN is valied quite expensively at the moment, while it does show a decent growth rate. This makes PHN very considerable for quality investing!
1. Profitability
1.1 Basic Checks
In the past year PHN was profitable.
PHN had a positive operating cash flow in the past year.
In the past 5 years PHN has always been profitable.
In the past 5 years PHN always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of PHN (18.51%) is better than 100.00% of its industry peers.
PHN has a Return On Equity of 36.34%. This is amongst the best in the industry. PHN outperforms 100.00% of its industry peers.
With an excellent Return On Invested Capital value of 24.17%, PHN belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for PHN is significantly above the industry average of 11.55%.
The 3 year average ROIC (18.48%) for PHN is below the current ROIC(24.17%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.51% | ||
| ROE | 36.34% | ||
| ROIC | 24.17% |
ROA(3y)15.25%
ROA(5y)18.05%
ROE(3y)27.89%
ROE(5y)30.2%
ROIC(3y)18.48%
ROIC(5y)19.46%
1.3 Margins
Looking at the Profit Margin, with a value of 13.57%, PHN belongs to the top of the industry, outperforming 84.62% of the companies in the same industry.
In the last couple of years the Profit Margin of PHN has declined.
PHN's Operating Margin of 22.46% is amongst the best of the industry. PHN outperforms 100.00% of its industry peers.
In the last couple of years the Operating Margin of PHN has declined.
PHN has a better Gross Margin (95.64%) than 100.00% of its industry peers.
In the last couple of years the Gross Margin of PHN has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 22.46% | ||
| PM (TTM) | 13.57% | ||
| GM | 95.64% |
OM growth 3Y-1.61%
OM growth 5Y-1.8%
PM growth 3Y-19.91%
PM growth 5Y-6.93%
GM growth 3Y0.82%
GM growth 5Y0.6%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), PHN is creating value.
The number of shares outstanding for PHN has been reduced compared to 1 year ago.
PHN has less shares outstanding than it did 5 years ago.
PHN has a worse debt/assets ratio than last year.
2.2 Solvency
PHN has an Altman-Z score of 9.52. This indicates that PHN is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 9.52, PHN belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
PHN has a debt to FCF ratio of 1.26. This is a very positive value and a sign of high solvency as it would only need 1.26 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.26, PHN belongs to the top of the industry, outperforming 84.62% of the companies in the same industry.
A Debt/Equity ratio of 0.35 indicates that PHN is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.35, PHN is in the better half of the industry, outperforming 61.54% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.35 | ||
| Debt/FCF | 1.26 | ||
| Altman-Z | 9.52 |
ROIC/WACC2.98
WACC8.11%
2.3 Liquidity
PHN has a Current Ratio of 2.26. This indicates that PHN is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 2.26, PHN belongs to the best of the industry, outperforming 92.31% of the companies in the same industry.
A Quick Ratio of 1.98 indicates that PHN should not have too much problems paying its short term obligations.
The Quick ratio of PHN (1.98) is better than 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.26 | ||
| Quick Ratio | 1.98 |
3. Growth
3.1 Past
PHN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -14.74%.
The Earnings Per Share has been growing by 8.59% on average over the past years. This is quite good.
The Revenue has grown by 14.28% in the past year. This is quite good.
PHN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.51% yearly.
EPS 1Y (TTM)-14.74%
EPS 3Y-2.81%
EPS 5Y8.59%
EPS Q2Q%69.23%
Revenue 1Y (TTM)14.28%
Revenue growth 3Y21.08%
Revenue growth 5Y16.51%
Sales Q2Q%25.66%
3.2 Future
The Earnings Per Share is expected to grow by 25.67% on average over the next years. This is a very strong growth
PHN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.89% yearly.
EPS Next Y43.02%
EPS Next 2Y30.62%
EPS Next 3Y25.67%
EPS Next 5YN/A
Revenue Next Year15.93%
Revenue Next 2Y14.69%
Revenue Next 3Y13.89%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 44.21 indicates a quite expensive valuation of PHN.
PHN's Price/Earnings ratio is rather expensive when compared to the industry. PHN is more expensive than 92.31% of the companies in the same industry.
PHN is valuated expensively when we compare the Price/Earnings ratio to 29.35, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 25.91, which means the current valuation is very expensive for PHN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PHN is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 22.10. PHN is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 44.21 | ||
| Fwd PE | 25.91 |
4.2 Price Multiples
61.54% of the companies in the same industry are cheaper than PHN, based on the Enterprise Value to EBITDA ratio.
PHN's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 29.3 | ||
| EV/EBITDA | 13.95 |
4.3 Compensation for Growth
PHN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PHN has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as PHN's earnings are expected to grow with 25.67% in the coming years.
PEG (NY)1.03
PEG (5Y)5.15
EPS Next 2Y30.62%
EPS Next 3Y25.67%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.47%, PHN has a reasonable but not impressive dividend return.
PHN's Dividend Yield is slightly below the industry average, which is at 2.32.
PHN's Dividend Yield is slightly below the S&P500 average, which is at 2.33.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.47% |
5.2 History
On average, the dividend of PHN grows each year by 19.41%, which is quite nice.
Dividend Growth(5Y)19.41%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
PHN pays out 38.19% of its income as dividend. This is a sustainable payout ratio.
PHN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP38.19%
EPS Next 2Y30.62%
EPS Next 3Y25.67%
BIT:PHN (3/7/2025, 7:00:00 PM)
58.8
+0.9 (+1.55%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners15.09%
Inst Owner ChangeN/A
Ins Owners65%
Ins Owner ChangeN/A
Market Cap569.18M
Analysts82.86
Price Target86.02 (46.29%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.47% |
Yearly Dividend0.8
Dividend Growth(5Y)19.41%
DP38.19%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)5.21%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.42%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 44.21 | ||
| Fwd PE | 25.91 | ||
| P/S | 3.61 | ||
| P/FCF | 29.3 | ||
| P/OCF | 24.89 | ||
| P/B | 9.66 | ||
| P/tB | 16.11 | ||
| EV/EBITDA | 13.95 |
EPS(TTM)1.33
EY2.26%
EPS(NY)2.27
Fwd EY3.86%
FCF(TTM)2.01
FCFY3.41%
OCF(TTM)2.36
OCFY4.02%
SpS16.3
BVpS6.08
TBVpS3.65
PEG (NY)1.03
PEG (5Y)5.15
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.51% | ||
| ROE | 36.34% | ||
| ROCE | 40.47% | ||
| ROIC | 24.17% | ||
| ROICexc | 33.51% | ||
| ROICexgc | 53.44% | ||
| OM | 22.46% | ||
| PM (TTM) | 13.57% | ||
| GM | 95.64% | ||
| FCFM | 12.31% |
ROA(3y)15.25%
ROA(5y)18.05%
ROE(3y)27.89%
ROE(5y)30.2%
ROIC(3y)18.48%
ROIC(5y)19.46%
ROICexc(3y)35.34%
ROICexc(5y)39.3%
ROICexgc(3y)54.37%
ROICexgc(5y)58.28%
ROCE(3y)31.09%
ROCE(5y)32.96%
ROICexcg growth 3Y-11.78%
ROICexcg growth 5Y-13.93%
ROICexc growth 3Y-16.83%
ROICexc growth 5Y-14.78%
OM growth 3Y-1.61%
OM growth 5Y-1.8%
PM growth 3Y-19.91%
PM growth 5Y-6.93%
GM growth 3Y0.82%
GM growth 5Y0.6%
F-Score7
Asset Turnover1.36
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.35 | ||
| Debt/FCF | 1.26 | ||
| Debt/EBITDA | 0.5 | ||
| Cap/Depr | 70.13% | ||
| Cap/Sales | 2.19% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 56.68% | ||
| Profit Quality | 90.76% | ||
| Current Ratio | 2.26 | ||
| Quick Ratio | 1.98 | ||
| Altman-Z | 9.52 |
F-Score7
WACC8.11%
ROIC/WACC2.98
Cap/Depr(3y)846.71%
Cap/Depr(5y)622.37%
Cap/Sales(3y)16.18%
Cap/Sales(5y)12.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14.74%
EPS 3Y-2.81%
EPS 5Y8.59%
EPS Q2Q%69.23%
EPS Next Y43.02%
EPS Next 2Y30.62%
EPS Next 3Y25.67%
EPS Next 5YN/A
Revenue 1Y (TTM)14.28%
Revenue growth 3Y21.08%
Revenue growth 5Y16.51%
Sales Q2Q%25.66%
Revenue Next Year15.93%
Revenue Next 2Y14.69%
Revenue Next 3Y13.89%
Revenue Next 5YN/A
EBIT growth 1Y0.74%
EBIT growth 3Y19.13%
EBIT growth 5Y14.41%
EBIT Next Year49.84%
EBIT Next 3Y24.24%
EBIT Next 5Y13.46%
FCF growth 1Y214.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y41.6%
OCF growth 3Y0.82%
OCF growth 5Y13.45%